Saltar al contenido principal

The Design of Covalent-Based Inhibitors

  • 1 Edición, Volumen 56 - 9 de julio de 2021
  • Última edición
  • Editores: Richard A Ward, Neil Grimster
  • Idioma: Inglés

Annual Report on Medicinal Chemistry series, highlights new advances in the field with this new volume presenting interesting chapters. Each chapter is written by an intern… Leer más

Descripción

Annual Report on Medicinal Chemistry series, highlights new advances in the field with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.

Puntos claves

  • Provides the authority and expertise of leading contributors from an international board of authors
  • Presents the latest release in the Annual Report on Medicinal Chemistry series
  • Updated release includes the latest information on The Design of Covalent-Based Inhibitors

De interès para

Undergraduates, graduates, academics, and researchers in the field of medicinal chemistry

Índice

Preface
Richard Andrew Ward and Neil Grimster

1. The history of covalent inhibitors
Renato A. Bauer

2. Kinetic Mechanisms of Covalent Inhibition
Claire Louise McWhirter

3. Covalent Drugs in Development for Immune-Mediated Diseases
Leonard Sung

4. Chemistry Perspectives of Reversible Covalent Drugs
Jianmin Gao

5. Design of Next-Generation Covalent Inhibitors: Targeting Residues Beyond Cysteine
Lyn Jones

6. Boron and Covalent Inhibition
Andrew Leach

7. Measuring and predicting warhead and residue reactivity
Christopher Rowley

8. Computational Support of Structure-based Targeted Covalent Inhibitor Design
Robert Abel

9. Novel approaches to covalent inhibition
Nir London

10. The future of covalent inhibition
Gyorgy M. Keseru

Detalles del producto

  • Edición: 1
  • Última edición
  • Volumen: 56
  • Publicado: 9 de julio de 2021
  • Idioma: Inglés

Sobre los editores

RW

Richard A Ward

Richard A. Ward is at AstraZeneca, UK
Afiliaciones y experiencia
AstraZeneca, UK

NG

Neil Grimster

Neil Grimster is at AstraZeneca, USA
Afiliaciones y experiencia
AstraZeneca, USA

Ver libro en ScienceDirect

Lee The Design of Covalent-Based Inhibitors en ScienceDirect